1 Electromyogram and Nerve Conduction Test Market Overview
1.1 Product Overview and Scope of Electromyogram and Nerve Conduction Test
1.2 Electromyogram and Nerve Conduction Test Segment by Type
1.2.1 Global Electromyogram and Nerve Conduction Test Market Value Comparison by Type (2023-2029)
1.2.2 Electromyogram Test
1.2.3 Nerve Conduction Test
1.3 Electromyogram and Nerve Conduction Test Segment by Application
1.3.1 Global Electromyogram and Nerve Conduction Test Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Research Institutes
1.3.4 Pharmaceutical Companies
1.3.5 Others
1.4 Global Electromyogram and Nerve Conduction Test Market Size Estimates and Forecasts
1.4.1 Global Electromyogram and Nerve Conduction Test Revenue 2018-2029
1.4.2 Global Electromyogram and Nerve Conduction Test Sales 2018-2029
1.4.3 Global Electromyogram and Nerve Conduction Test Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Electromyogram and Nerve Conduction Test Market Competition by Manufacturers
2.1 Global Electromyogram and Nerve Conduction Test Sales Market Share by Manufacturers (2018-2023)
2.2 Global Electromyogram and Nerve Conduction Test Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Electromyogram and Nerve Conduction Test Average Price by Manufacturers (2018-2023)
2.4 Global Electromyogram and Nerve Conduction Test Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Electromyogram and Nerve Conduction Test, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Electromyogram and Nerve Conduction Test, Product Type & Application
2.7 Electromyogram and Nerve Conduction Test Market Competitive Situation and Trends
2.7.1 Electromyogram and Nerve Conduction Test Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Electromyogram and Nerve Conduction Test Players Market Share by Revenue
2.7.3 Global Electromyogram and Nerve Conduction Test Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Electromyogram and Nerve Conduction Test Retrospective Market Scenario by Region
3.1 Global Electromyogram and Nerve Conduction Test Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Electromyogram and Nerve Conduction Test Global Electromyogram and Nerve Conduction Test Sales by Region: 2018-2029
3.2.1 Global Electromyogram and Nerve Conduction Test Sales by Region: 2018-2023
3.2.2 Global Electromyogram and Nerve Conduction Test Sales by Region: 2024-2029
3.3 Global Electromyogram and Nerve Conduction Test Global Electromyogram and Nerve Conduction Test Revenue by Region: 2018-2029
3.3.1 Global Electromyogram and Nerve Conduction Test Revenue by Region: 2018-2023
3.3.2 Global Electromyogram and Nerve Conduction Test Revenue by Region: 2024-2029
3.4 North America Electromyogram and Nerve Conduction Test Market Facts & Figures by Country
3.4.1 North America Electromyogram and Nerve Conduction Test Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Electromyogram and Nerve Conduction Test Sales by Country (2018-2029)
3.4.3 North America Electromyogram and Nerve Conduction Test Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Electromyogram and Nerve Conduction Test Market Facts & Figures by Country
3.5.1 Europe Electromyogram and Nerve Conduction Test Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Electromyogram and Nerve Conduction Test Sales by Country (2018-2029)
3.5.3 Europe Electromyogram and Nerve Conduction Test Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Electromyogram and Nerve Conduction Test Market Facts & Figures by Country
3.6.1 Asia Pacific Electromyogram and Nerve Conduction Test Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Electromyogram and Nerve Conduction Test Sales by Country (2018-2029)
3.6.3 Asia Pacific Electromyogram and Nerve Conduction Test Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Electromyogram and Nerve Conduction Test Market Facts & Figures by Country
3.7.1 Latin America Electromyogram and Nerve Conduction Test Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Electromyogram and Nerve Conduction Test Sales by Country (2018-2029)
3.7.3 Latin America Electromyogram and Nerve Conduction Test Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Electromyogram and Nerve Conduction Test Market Facts & Figures by Country
3.8.1 Middle East and Africa Electromyogram and Nerve Conduction Test Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Electromyogram and Nerve Conduction Test Sales by Country (2018-2029)
3.8.3 Middle East and Africa Electromyogram and Nerve Conduction Test Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Electromyogram and Nerve Conduction Test Sales by Type (2018-2029)
4.1.1 Global Electromyogram and Nerve Conduction Test Sales by Type (2018-2023)
4.1.2 Global Electromyogram and Nerve Conduction Test Sales by Type (2024-2029)
4.1.3 Global Electromyogram and Nerve Conduction Test Sales Market Share by Type (2018-2029)
4.2 Global Electromyogram and Nerve Conduction Test Revenue by Type (2018-2029)
4.2.1 Global Electromyogram and Nerve Conduction Test Revenue by Type (2018-2023)
4.2.2 Global Electromyogram and Nerve Conduction Test Revenue by Type (2024-2029)
4.2.3 Global Electromyogram and Nerve Conduction Test Revenue Market Share by Type (2018-2029)
4.3 Global Electromyogram and Nerve Conduction Test Price by Type (2018-2029)
5 Segment by Application
5.1 Global Electromyogram and Nerve Conduction Test Sales by Application (2018-2029)
5.1.1 Global Electromyogram and Nerve Conduction Test Sales by Application (2018-2023)
5.1.2 Global Electromyogram and Nerve Conduction Test Sales by Application (2024-2029)
5.1.3 Global Electromyogram and Nerve Conduction Test Sales Market Share by Application (2018-2029)
5.2 Global Electromyogram and Nerve Conduction Test Revenue by Application (2018-2029)
5.2.1 Global Electromyogram and Nerve Conduction Test Revenue by Application (2018-2023)
5.2.2 Global Electromyogram and Nerve Conduction Test Revenue by Application (2024-2029)
5.2.3 Global Electromyogram and Nerve Conduction Test Revenue Market Share by Application (2018-2029)
5.3 Global Electromyogram and Nerve Conduction Test Price by Application (2018-2029)
6 Key Companies Profiled
6.1 ProScan Imaging
6.1.1 ProScan Imaging Corporation Information
6.1.2 ProScan Imaging Description and Business Overview
6.1.3 ProScan Imaging Electromyogram and Nerve Conduction Test Sales, Revenue and Gross Margin (2018-2023)
6.1.4 ProScan Imaging Electromyogram and Nerve Conduction Test Product Portfolio
6.1.5 ProScan Imaging Recent Developments/Updates
6.2 CoxHealth
6.2.1 CoxHealth Corporation Information
6.2.2 CoxHealth Description and Business Overview
6.2.3 CoxHealth Electromyogram and Nerve Conduction Test Sales, Revenue and Gross Margin (2018-2023)
6.2.4 CoxHealth Electromyogram and Nerve Conduction Test Product Portfolio
6.2.5 CoxHealth Recent Developments/Updates
6.3 Cadwell Industries
6.3.1 Cadwell Industries Corporation Information
6.3.2 Cadwell Industries Description and Business Overview
6.3.3 Cadwell Industries Electromyogram and Nerve Conduction Test Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Cadwell Industries Electromyogram and Nerve Conduction Test Product Portfolio
6.3.5 Cadwell Industries Recent Developments/Updates
6.4 Compumedics
6.4.1 Compumedics Corporation Information
6.4.2 Compumedics Description and Business Overview
6.4.3 Compumedics Electromyogram and Nerve Conduction Test Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Compumedics Electromyogram and Nerve Conduction Test Product Portfolio
6.4.5 Compumedics Recent Developments/Updates
6.5 Electrical Geodesics
6.5.1 Electrical Geodesics Corporation Information
6.5.2 Electrical Geodesics Description and Business Overview
6.5.3 Electrical Geodesics Electromyogram and Nerve Conduction Test Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Electrical Geodesics Electromyogram and Nerve Conduction Test Product Portfolio
6.5.5 Electrical Geodesics Recent Developments/Updates
6.6 Natus Medical
6.6.1 Natus Medical Corporation Information
6.6.2 Natus Medical Description and Business Overview
6.6.3 Natus Medical Electromyogram and Nerve Conduction Test Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Natus Medical Electromyogram and Nerve Conduction Test Product Portfolio
6.6.5 Natus Medical Recent Developments/Updates
6.7 NIHON KOHDEN
6.6.1 NIHON KOHDEN Corporation Information
6.6.2 NIHON KOHDEN Description and Business Overview
6.6.3 NIHON KOHDEN Electromyogram and Nerve Conduction Test Sales, Revenue and Gross Margin (2018-2023)
6.4.4 NIHON KOHDEN Electromyogram and Nerve Conduction Test Product Portfolio
6.7.5 NIHON KOHDEN Recent Developments/Updates
6.8 Medtronic (Covidien)
6.8.1 Medtronic (Covidien) Corporation Information
6.8.2 Medtronic (Covidien) Description and Business Overview
6.8.3 Medtronic (Covidien) Electromyogram and Nerve Conduction Test Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Medtronic (Covidien) Electromyogram and Nerve Conduction Test Product Portfolio
6.8.5 Medtronic (Covidien) Recent Developments/Updates
6.9 Philips Healthcare
6.9.1 Philips Healthcare Corporation Information
6.9.2 Philips Healthcare Description and Business Overview
6.9.3 Philips Healthcare Electromyogram and Nerve Conduction Test Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Philips Healthcare Electromyogram and Nerve Conduction Test Product Portfolio
6.9.5 Philips Healthcare Recent Developments/Updates
6.10 Micromed S.p.A.
6.10.1 Micromed S.p.A. Corporation Information
6.10.2 Micromed S.p.A. Description and Business Overview
6.10.3 Micromed S.p.A. Electromyogram and Nerve Conduction Test Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Micromed S.p.A. Electromyogram and Nerve Conduction Test Product Portfolio
6.10.5 Micromed S.p.A. Recent Developments/Updates
6.11 Noraxon
6.11.1 Noraxon Corporation Information
6.11.2 Noraxon Electromyogram and Nerve Conduction Test Description and Business Overview
6.11.3 Noraxon Electromyogram and Nerve Conduction Test Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Noraxon Electromyogram and Nerve Conduction Test Product Portfolio
6.11.5 Noraxon Recent Developments/Updates
6.12 MYON
6.12.1 MYON Corporation Information
6.12.2 MYON Electromyogram and Nerve Conduction Test Description and Business Overview
6.12.3 MYON Electromyogram and Nerve Conduction Test Sales, Revenue and Gross Margin (2018-2023)
6.12.4 MYON Electromyogram and Nerve Conduction Test Product Portfolio
6.12.5 MYON Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Electromyogram and Nerve Conduction Test Industry Chain Analysis
7.2 Electromyogram and Nerve Conduction Test Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Electromyogram and Nerve Conduction Test Production Mode & Process
7.4 Electromyogram and Nerve Conduction Test Sales and Marketing
7.4.1 Electromyogram and Nerve Conduction Test Sales Channels
7.4.2 Electromyogram and Nerve Conduction Test Distributors
7.5 Electromyogram and Nerve Conduction Test Customers
8 Electromyogram and Nerve Conduction Test Market Dynamics
8.1 Electromyogram and Nerve Conduction Test Industry Trends
8.2 Electromyogram and Nerve Conduction Test Market Drivers
8.3 Electromyogram and Nerve Conduction Test Market Challenges
8.4 Electromyogram and Nerve Conduction Test Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
| ※参考情報 筋電図（EMG）および神経伝導検査（NCS）は、神経と筋肉の機能を評価するための重要な診断技術です。これらの検査は、神経系や筋肉系の異常を特定するために広く使用されています。これらを通じて、医師は多くの神経疾患や筋疾患の診断を行うことができます。 筋電図は、筋肉の電気的活動を記録する方法です。筋肉が収縮する際には、神経からの信号によって筋繊維が活性化され、その結果として電気的な信号が生成されます。EMGは、この電気信号を検出し、筋肉の状態を評価します。例えば、筋肉の疲労や損傷、神経の障害などがEMGに反映されます。 一方、神経伝導検査は、神経が刺激に対してどのように反応するかを評価します。この検査では、神経に対して小さな電気刺激を与え、その反応がどのように伝わるかを測定します。特に、神経が信号をどれだけ速く、または正常に伝達するかを確認することができ、特定の神経障害や圧迫による障害を識別するのに役立ちます。 これらの検査にはいくつかの特徴があります。まず、非侵襲的であるため、患者に対して比較的安全です。一般的には診療所や病院の専門的な環境で行われます。また、即時の結果が得られるため、診断に迅速に対応することが可能です。多くの場合、神経科や整形外科、リハビリテーション科などの領域で実施されます。 筋電図には主に2つのタイプがあります。1つは針筋電図で、細い針を筋肉に挿入して電気信号を測定します。この方法では、筋肉の電気的な動作を高い解像度で観察できます。もう1つは表面筋電図で、皮膚の上から電極を配置して筋電活動を記録します。これは非侵襲的であり、複数の筋肉を同時に評価することができますが、針筋電図よりも解像度は低くなります。 神経伝導検査も複数の方法で実施されます。一般的な手法では、神経の特定の部位に電気刺激を与え、筋肉の反応を測定することによって、神経の伝導速度を評価します。これにより、神経の損傷の有無やその程度を確認できます。また、神経が圧迫されている場合や、神経障害が疑われる場合に有効です。 これらの検査の主な用途は多岐にわたります。まず、筋萎縮性側索硬化症（ALS）やギラン・バレー症候群、末梢神経障害、筋ジストロフィーなどの神経および筋の疾患の診断に利用されます。また、外傷後の神経の回復過程を評価するためや、手術の前後の状態を比較するためにも用いられます。リハビリテーションの過程においては、筋肉や神経の機能回復を評価するために重要なパラメータを提供します。 関連する技術としては、画像診断法が挙げられます。CTやMRIなどの画像検査によって、筋肉や神経の構造的な問題を可視化することができます。これにより、筋電図や神経伝導検査で得られた情報を補完し、より正確な診断を下すための助けとなります。また、近年はAI技術の進歩により、EMGやNCSの解析においても人工知能が活用されるようになっています。これにより、大量のデータを迅速に処理し、診断の精度を向上させることが期待されています。 筋電図および神経伝導検査は、神経と筋肉の健康状態を評価するために不可欠なツールであり、適切な診断と治療計画を立てるために欠かせません。これらの検査を通して得られた結果は、患者の治療方針に大きな影響を与えます。医療現場ではこれらの技術を活用し、さらなる精度向上を目指す研究が続けられています。患者にとってより良い医療を提供するためには、筋電図と神経伝導検査の理解は欠かせない要素となっています。 |
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
